You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 04/22/2014

Company Name Symbol %Change
CELL THERAPE CTIC
11.37%
CANADIAN SOL CSIQ
9.45%
ZIOPHARM ONC ZIOP
8.26%
ENANTA PHARM ENTA
7.38%
MOTORCAR PAR MPAA
7.29%

Eric Dutram

Interests :

  • ETFs

Connect :

Share
Eric Dutram

ETF Strategist

RSS Feed | Email This Author

Latest Comments on Eric Dutram's Articles

About

Eric is in charge of developing the ETF portion of the Zacks website, focusing on writing articles and coordinating strategy for these increasingly popular investment tools. Prior to joining Zacks, Eric worked as an ETF Analyst and Head of Editorial at ETF Database where he was in charge of all content and day-to-day operations of the website.

Eric received a Bachelor of Science from DePaul University, graduating cum laude with a double major in Accounting and Finance and a History minor.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.